The promiscuity of ARF interactions with the proteasome

被引:24
作者
Pollice, Alessandra [1 ]
Vivo, Maria [1 ]
La Mantia, Girolama [1 ]
机构
[1] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy
关键词
p14/p19ARF; Proteasome; Cell stress sensor; REG-gamma; TBP-1/PSMC3;
D O I
10.1016/j.febslet.2008.09.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor ARF is one of the most important oncogenic stress sensors in mammalian cells. Its effect is exerted through the interaction with different cellular partners, often resulting in their functional inactivation. This review focuses on the role played by the proteasome in ARF regulation of protein turnover and the function of most of its interacting partners. Specific proteasome components appear to be involved in the regulation of ARF turnover, bringing to light a complex network of interactions between ARF and the proteasome. (C) 2008 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:3257 / 3262
页数:6
相关论文
共 69 条
[1]   The proteasome: A suitable antineoplastic target [J].
Adams, J .
NATURE REVIEWS CANCER, 2004, 4 (05) :349-360
[2]   A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73 [J].
Asher, G ;
Tsvetkov, P ;
Kahana, C ;
Shaul, Y .
GENES & DEVELOPMENT, 2005, 19 (03) :316-321
[3]   HBV X protein targets HIV tat-binding protein 1 [J].
Barak, O ;
Aronheim, A ;
Shaul, Y .
VIROLOGY, 2001, 283 (01) :110-120
[4]   Growth factor regulation of a 26S proteasomal subunit in breast cancer [J].
Barnes, CJ ;
Li, F ;
Talukder, AH ;
Kumar, R .
CLINICAL CANCER RESEARCH, 2005, 11 (08) :2868-2874
[5]   Immune defects in 28-kDa proteasome activator γ-deficient mice [J].
Barton, LF ;
Runnels, HA ;
Schell, TD ;
Cho, YJ ;
Gibbons, R ;
Tevethia, SS ;
Deepe, GS ;
Monaco, JJ .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3948-3954
[6]   The tumor suppressor protein p16INK4a and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system -: Direct evidence for ubiquitination at the N-terminal residue [J].
Ben-Saadon, R ;
Fajerman, I ;
Ziv, T ;
Hellman, U ;
Schwartz, AL ;
Ciechanover, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) :41414-41421
[7]   Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 [J].
Bertwistle, D ;
Sugimoto, M ;
Sherr, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :985-996
[8]   A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter [J].
Brès, V ;
Kiernan, RE ;
Linares, LK ;
Chable-Bessia, C ;
Plechakova, O ;
Tréand, C ;
Emiliani, S ;
Peloponese, JM ;
Jeang, KT ;
Coux, O ;
Scheffner, M ;
Benkirane, M .
NATURE CELL BIOLOGY, 2003, 5 (08) :754-761
[9]   Subcellular localization of proteasomes and their regulatory complexes in mammalian cells [J].
Brooks, P ;
Fuertes, G ;
Murray, RZ ;
Bose, S ;
Knecht, E ;
Rechsteiner, MC ;
Hendil, KB ;
Tanaka, K ;
Dyson, J ;
Rivett, AJ .
BIOCHEMICAL JOURNAL, 2000, 346 :155-161
[10]   Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia [J].
Brusselmans, K ;
Compernolle, V ;
Tjwa, M ;
Wiesener, MS ;
Maxwell, PH ;
Collen, D ;
Carmeliet, P .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1519-1527